Literature DB >> 8939199

Proteinase-K-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease (Indiana kindred).

P Piccardo1, C Seiler, S R Dlouhy, K Young, M R Farlow, F Prelli, B Frangione, O Bugiani, F Tagliavini, B Ghetti.   

Abstract

Gerstmann-Sträussler-Scheinker (GSS) disease is a cerebral prion protein (PrP) amyloidosis associated with mutations in the PrP gene (PRNP). A GSS disease variant with mutation at codon 198 (F198S) has been studied in a large Indiana kindred. Biochemical investigations showed that the amyloid protein consists of 11 and 7 kDa fragments of PrP. Immunohistochemical studies showed that in addition to amyloid, these patients accumulate PrP deposits which are neither fluorescent nor birefringent when stained with thioflavin S and Congo red. In the present paper, we analyzed proteinase-K (PK)-resistant PrP in 7 patients with GSS F198S disease. Immunoblots of PK-treated brain extracts show prominent bands of ca. 27-29, 18-19, and 8 kDa. Immunohistochemistry and thioflavin-S-fluorescence show that the amyloid deposits are conspicuous in the cerebellum but sparse in the caudate nucleus. However, immunoblot analysis reveals PK-resistant PrP bands of similar intensity in both regions. Treatment with PK and PNGase F generates a pattern similar to that of PK alone. Our findings suggest that brain extracts from GSS F198S disease contain 3 prominent nonglycosylated PK-resistant PrP fragments forming a pattern not previously described in other prion diseases, which may in part explain the pathology of this GSS disease variant.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8939199     DOI: 10.1097/00005072-199611000-00007

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  22 in total

1.  Non-amyloid and amyloid prion protein deposits in prion-infected mice differ in blockage of interstitial brain fluid.

Authors:  A Rangel; B Race; J Striebel; B Chesebro
Journal:  Neuropathol Appl Neurobiol       Date:  2013-04       Impact factor: 8.090

2.  Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations.

Authors:  P Piccardo; J J Liepnieks; A William; S R Dlouhy; M R Farlow; K Young; D Nochlin; T D Bird; R R Nixon; M J Ball; C DeCarli; O Bugiani; F Tagliavini; M D Benson; B Ghetti
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

3.  An antibody raised against a conserved sequence of the prion protein recognizes pathological isoforms in human and animal prion diseases, including Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.

Authors:  P Piccardo; J P Langeveld; A F Hill; S R Dlouhy; K Young; G Giaccone; G Rossi; M Bugiani; O Bugiani; R H Meloen; J Collinge; F Tagliavini; B Ghetti
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

4.  Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.

Authors:  Bruce Chesebro; Brent Race; Kimberly Meade-White; Rachel Lacasse; Richard Race; Mikael Klingeborn; James Striebel; David Dorward; Gillian McGovern; Martin Jeffrey
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

5.  A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report.

Authors:  Ana B Rodríguez-Martínez; Joseba M Garrido; Juan J Zarranz; Jose M Arteagoitia; Marian M de Pancorbo; Begoña Atarés; Miren J Bilbao; Isidro Ferrer; Ramón A Juste
Journal:  BMC Neurol       Date:  2010-10-25       Impact factor: 2.474

6.  Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease.

Authors:  P Parchi; S G Chen; P Brown; W Zou; S Capellari; H Budka; J Hainfellner; P F Reyes; G T Golden; J J Hauw; D C Gajdusek; P Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

7.  H-type bovine spongiform encephalopathy: complex molecular features and similarities with human prion diseases.

Authors:  Anne-Gaëlle Biacabe; Jorg G Jacobs; Anna Bencsik; Jan P M Langeveld; Thierry G M Baron
Journal:  Prion       Date:  2007-01-11       Impact factor: 3.931

8.  Neurotoxic and gliotrophic activity of a synthetic peptide homologous to Gerstmann-Sträussler-Scheinker disease amyloid protein.

Authors:  Luana Fioriti; Nadia Angeretti; Laura Colombo; Ada De Luigi; Alessio Colombo; Claudia Manzoni; Michela Morbin; Fabrizio Tagliavini; Mario Salmona; Roberto Chiesa; Gianluigi Forloni
Journal:  J Neurosci       Date:  2007-02-14       Impact factor: 6.167

9.  Small ruminant nor98 prions share biochemical features with human gerstmann-sträussler-scheinker disease and variably protease-sensitive prionopathy.

Authors:  Laura Pirisinu; Romolo Nonno; Elena Esposito; Sylvie L Benestad; Pierluigi Gambetti; Umberto Agrimi; Wen-Quan Zou
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

10.  Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions.

Authors:  Patricia Aguilar-Calvo; Alejandro M Sevillano; Jaidev Bapat; Katrin Soldau; Daniel R Sandoval; Hermann C Altmeppen; Luise Linsenmeier; Donald P Pizzo; Michael D Geschwind; Henry Sanchez; Brian S Appleby; Mark L Cohen; Jiri G Safar; Steven D Edland; Markus Glatzel; K Peter R Nilsson; Jeffrey D Esko; Christina J Sigurdson
Journal:  Acta Neuropathol       Date:  2019-10-31       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.